American Association for Cancer Research® (AACR) Annual Meeting 2024

Article collection

We are proud to present a special collection of articles for the American Association for Cancer Research^® (AACR) Annual Meeting 2024. This curated selection showcases the cutting-edge advancements and novel perspectives published in journals from Elsevier's Oncology Journal Network. We invite you to explore this collection and delve deeper into the exciting advancements shaping the future of cancer research.

Annals of Oncology

• ●

  Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer(打開新的分頁／視窗)

Blood Neoplasia

• ●

  Comparison of TP53 Mutations in Myelodysplasia and Acute Leukemia Suggests Divergent Roles in Initiation and Progression(打開新的分頁／視窗)

Cancer Epidemiology

• ●

  Latin America and the Caribbean Code Against Cancer 1st Edition: A landmark for cancer prevention in the region(打開新的分頁／視窗)

• ●

  Association of the affordable care act with perceived health care quality of cancer survivors(打開新的分頁／視窗)

Cancer Letters

• ●

  Editorial: The progress and challenges of hematological malignancies in the era of big data and new therapy(打開新的分頁／視窗)

• ●

  Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions(打開新的分頁／視窗)

• ●

  The past, present, and future of liver cancer research in China(打開新的分頁／視窗)

• ●

  Ferroptosis: Promising approach for cancer and cancer immunotherapy(打開新的分頁／視窗)

• ●

  Tackling the current dilemma of immunotherapy in extensive-stage small cell lung cancer: A promising strategy of combining with radiotherapy(打開新的分頁／視窗)

• ●

  Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?(打開新的分頁／視窗)

• ●

  Novel strategies optimize immunotherapy by improving the cytotoxic function of T cells for pancreatic cancer treatment(打開新的分頁／視窗)

• ●

  PROTACs: Novel tools for improving immunotherapy in cancer(打開新的分頁／視窗)

Cancer Pathogenesis and Therapy

• ●

  Role of T cells in cancer immunotherapy: Opportunities and challenges(打開新的分頁／視窗)

• ●

  PI3K/AKT/mTOR pathway, hypoxia, and glucose metabolism: Potential targets to overcome radioresistance in small cell lung cancer(打開新的分頁／視窗)

• ●

  Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005–2018)(打開新的分頁／視窗)

Cancer Treatment and Research Communications

• ●

  Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in advanced non-small cell lung cancer(打開新的分頁／視窗)

Cancer Treatment Reviews

• ●

  Histology independent drug development – Is this the future for cancer drugs?(打開新的分頁／視窗)

• ●

  Breaking barriers in triple negative breast cancer (TNBC) – Unleashing the power of antibody-drug conjugates (ADCs)(打開新的分頁／視窗)

Chinese Medical Journal Pulmonary and Critical Care Medicine

• ●

  Role of c-Myc in lung cancer: Progress, challenges, and prospects(打開新的分頁／視窗)

• ●

  Pyroptosis: A promising target for lung cancer therapy(打開新的分頁／視窗)

• ●

  Changing profile of lung cancer clinical characteristics in China: Over 8-year population-based study(打開新的分頁／視窗)

Clinical Breast Cancer

• ●

  Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics(打開新的分頁／視窗)

• ●

  Efficacy and Safety of Trastuzumab Deruxtecan in Breast Cancer: A Systematic Review and Meta-Analysis(打開新的分頁／視窗)

Clinical Colorectal Cancer

• ●

  Incidence of Disease Recurrence in Patients With Colon and Upper Rectum Adenocarcinoma Stage II and III Receiving Adjuvant Capecitabine Monotherapy: Do Number of Chemotherapy Cycles and Relative Dose Intensity of the Drug Play a Role?(打開新的分頁／視窗)

• ●

  Systemic Therapy for Patients With Pancreatic Cancer: Current Approaches and Opportunities for Novel Avenues Toward Precision Medicine(打開新的分頁／視窗)

Clinical Genitourinary Cancer

• ●

  The Impact of Blue Light Cystoscopy Use Among Nonmuscle Invasive Bladder Cancer Patients in an Equal Access Setting: Implications on Recurrence and Time to Recurrence(打開新的分頁／視窗)

• ●

  A Phase I Study of Capivasertib in Combination With Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer(打開新的分頁／視窗)

Clinical Imaging

• ●

  A comprehensive survey of deep learning research on medical image analysis with focus on transfer learning(打開新的分頁／視窗)

• ●

  Decoding radiology reports: Potential application of OpenAI ChatGPT to enhance patient understanding of diagnostic reports(打開新的分頁／視窗)

• ●

  CT radiomics for differentiating oncocytoma from renal cell carcinomas: Systematic review and meta-analysis(打開新的分頁／視窗)

Clinical Lung Cancer

• ●

  Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and Mesenchymal-epithelial Transition Factor (MET) Bispecific Antibody, Designed to Enable Multiple Mechanisms of Action and Broad Clinical Applications(打開新的分頁／視窗)

• ●

  A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non–Small Cell Lung Cancer(打開新的分頁／視窗)

Clinical Lymphoma Myeloma and Leukemia

• ●

  Progression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma: TAURUS Chart Review Study(打開新的分頁／視窗)

• ●

  Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma(打開新的分頁／視窗)

Clinical Surgical Oncology

• ●

  Impact of diverting stoma on long-term survival in patients with rectal cancer: A nationwide study based on health insurance claims data(打開新的分頁／視窗)

• ●

  Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (V. 2023)(打開新的分頁／視窗)

Clinics

• ●

  Could be FOXO3a, miR-96-5p and miR-182-5p useful for Brazilian women with luminal A and triple negative breast cancers prognosis and target therapy?(打開新的分頁／視窗)

• ●

  Programmed cell death-1 and its ligands: Current knowledge and possibilities in immunotherapy(打開新的分頁／視窗)

Critical Reviews in Oncology/Hematology

• ●

  Characteristics of gastric cancer around the world(打開新的分頁／視窗)

• ●

  Ferroptosis induction via targeting metabolic alterations in head and neck cancer(打開新的分頁／視窗)

Current Problems in Cancer

• ●

  Folate Receptor as a Biomarker and Therapeutic Target in Solid Tumors(打開新的分頁／視窗)

• ●

  Tisotumab vedotin in recurrent or metastatic cervical cancer(打開新的分頁／視窗)

• ●

  Comparative effect of progressive relaxation technique and Benson's technique on anxiety and fatigue in cancer survivors - an experimental study(打開新的分頁／視窗)

EJC: Paediatric Oncology

• ●

  The impact of infertility and physical late effects on psycho-social well-being of long-term childhood cancer survivors: A cross-sectional study(打開新的分頁／視窗)

• ●

  Olfactory neuroblastoma in children and adolescents: The EXPeRT recommendations for diagnosis and management(打開新的分頁／視窗)

EJC Skin Cancer

• ●

  Quality of life issues faced by patients with keratinocyte cancer: A systematic review(打開新的分頁／視窗)

• ●

  Spontaneous haematoma: A unique immune-related adverse event alongside other cutaneous reactions in a patient treated with pembrolizumab for metastatic melanoma(打開新的分頁／視窗)

• ●

  Merkel cell carcinoma with leptomeningeal involvement: A complex case report(打開新的分頁／視窗)

ESMO Gastrointestinal Oncology

• ●

  Unleashing the power of anti-HER2 therapies in metastatic colorectal cancer: paving the way for a brighter future(打開新的分頁／視窗)

ESMO Open

• ●

  Artificial intelligence for detection of microsatellite instability in colorectal cancer—a multicentric analysis of a pre-screening tool for clinical application(打開新的分頁／視窗)

• ●

  Effectiveness of next-generation sequencing for patients with advanced non-small-cell lung cancer: a population-based registry study(打開新的分頁／視窗)

ESMO Real World Data and Digital Oncology

• ●

  Relationship of tumor fraction in circulating tumor DNA with prognosis in patients with advanced urothelial cancer(打開新的分頁／視窗)

European Journal of Cancer

• ●

  Recent advances and future strategies in first-line treatment of ES-SCLC(打開新的分頁／視窗)

• ●

  Cross-trial comparisons for the adjuvant treatment of MSI colorectal cancer: dare to dream the future scenarios.(打開新的分頁／視窗)

• ●

  Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectives(打開新的分頁／視窗)

• ●

  A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305(打開新的分頁／視窗)

Gynecologic Oncology

• ●

  Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO)(打開新的分頁／視窗)

• ●

  Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update(打開新的分頁／視窗)

• ●

  Financial toxicity: A practical review for gynecologic oncology teams to understand and address patient-level financial burdens(打開新的分頁／視窗)

• ●

  Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma(打開新的分頁／視窗)

Gynecologic Oncology Reports

• ●

  Strategies for prevention and management of ocular events occurring with mirvetuximab soravtansine(打開新的分頁／視窗)

• ●

  Digital cervicography for cervical cancer screening in low-resource settings: A scoping review(打開新的分頁／視窗)

• ●

  Activity of pembrolizumab and lenvatinib in mismatch repair deficient (dMMR) endometrial cancer patients who have failed pembrolizumab monotherapy: A case series(打開新的分頁／視窗)

Hematology, Transfusion and Cell Therapy

• ●

  CAR-T cell therapy for multiple myeloma: a practical toolkit for treatment in Brazil(打開新的分頁／視窗)

Immuno-Oncology and Technology

• ●

  CD47–SIRPα-targeted therapeutics: status and prospects(打開新的分頁／視窗)

• ●

  Quantitative RNA assessment and long-term stability in the FFPE tumor samples using Digital Spatial Profiler(打開新的分頁／視窗)

• ●

  Basics of advanced therapy medicinal product development in academic pharma and the role of a GMP simulation unit(打開新的分頁／視窗)

Journal of Bone Oncology

• ●

  Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations(打開新的分頁／視窗)

• ●

  Optimization of a syngeneic murine model of bone metastasis(打開新的分頁／視窗)

Journal of Cancer Policy

• ●

  Cross-cultural adaptation of the PROFFIT Instrument to measure financial toxicity in people living with cancer within a UK population(打開新的分頁／視窗)

• ●

  Effect of a same day appointment initiative on racial disparities in access for radiation oncology(打開新的分頁／視窗)

Journal of Geriatric Oncology

• ●

  Predicting future cancer incidence by age, race, ethnicity, and sex(打開新的分頁／視窗)

• ●

  Impact of pharmaceutical care interventions on multidisciplinary care of older patients with cancer: A systematic review(打開新的分頁／視窗)

• ●

  A scoping review of ageism towards older adults in cancer care(打開新的分頁／視窗)

Journal of Liquid Biopsy

• ●

  Liquid biopsy in detecting early non-small cell lung cancer(打開新的分頁／視窗)

• ●

  Real-time assessment of HER2 status in circulating tumor cells of breast cancer patients: Methods of detection and clinical implications(打開新的分頁／視窗)

Journal of the National Cancer Center

• ●

  Cancer incidence and mortality in China, 2022(打開新的分頁／視窗)

• ●

  Chinese quality control indices for standardized diagnosis and treatment of renal cancer (2022 edition)(打開新的分頁／視窗)

• ●

  The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy(打開新的分頁／視窗)

Leukemia Research

• ●

  From bone marrow failure syndromes to VEXAS: Disentangling clonal hematopoiesis, immune system, and molecular drivers(打開新的分頁／視窗)

• ●

  Evaluation of the Simplified Score to Predict Early Relapse in Multiple Myeloma (S-ERMM) in the MMRF CoMMpass study(打開新的分頁／視窗)

Leukemia Research Reports

• ●

  Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)(打開新的分頁／視窗)

• ●

  Allogeneic stem cell transplant for multiple myeloma & myelofibrosis with split-dose busulfan, fludarabine & cyclophosphamide(打開新的分頁／視窗)

• ●

  Location, location, location: A mini-review of CEBPA variants in patients with acute myeloid leukemia(打開新的分頁／視窗)

Lung Cancer

• ●

  Lurbinectedin in patients with small cell lung cancer with chemotherapy-free interval ≥30 days and without central nervous metastases(打開新的分頁／視窗)

Medical Dosimetry

• ●

  Clinical target volume segmentation based on gross tumor volume using deep learning for head and neck cancer treatment(打開新的分頁／視窗)

• ●

  Dosimetric benefits of 3D-printed modulated electron bolus following lumpectomy and whole-breast radiotherapy for left breast cancer(打開新的分頁／視窗)

• ●

  Medical dosimetry virtual clinical education: Mentors’ perspectives(打開新的分頁／視窗)

Neoplasia

• ●

  UALCAN: An update to the integrated cancer data analysis platform(打開新的分頁／視窗)

• ●

  Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor(打開新的分頁／視窗)

• ●

  Acral melanoma: new insights into the immune and genomic landscape(打開新的分頁／視窗)

• ●

  Pioneering models of pediatric brain tumors(打開新的分頁／視窗)

• ●

  A sensitive and robust plasma-based DNA methylation panel for early detection of target gastrointestinal cancers(打開新的分頁／視窗)

• ●

  Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients – Knowledge from two independent international studies(打開新的分頁／視窗)

• ●

  Primary central nervous system germ cell tumors in children and young adults: A review of controversies in diagnostic and treatment approach(打開新的分頁／視窗)

• ●

  Dual inhibition of VEGF and PARP suppresses KRAS-mutant colorectal cancer(打開新的分頁／視窗)

• ●

  Epigenome-wide DNA methylation profiling of portal vein tumor thrombosis (PVTT) tissues in hepatocellular carcinoma patients(打開新的分頁／視窗)

• ●

  Current state of pediatric neuro-oncology imaging, challenges and future directions(打開新的分頁／視窗)

• ●

  Indigenous peoples and inclusion in clinical and genomic research: Understanding the history and navigating contemporary engagement(打開新的分頁／視窗)

Oral Oncology

• ●

  Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence(打開新的分頁／視窗)

• ●

  Functional considerations between flap and non-flap reconstruction in oral tongue cancer: A systematic review(打開新的分頁／視窗)

• ●

  Immunochemotherapy alone or immunochemotherapy plus subsequent locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma(打開新的分頁／視窗)

Oral Oncology Reports

• ●

  Bibliometrics study of the cancer research in the faculties of medicine and dentistry during Syrian crisis(打開新的分頁／視窗)

• ●

  Immune-related adverse events following checkpoint inhibitor treatment in head and neck cancers: A comprehensive review(打開新的分頁／視窗)

Photodiagnosis and Photodynamic Therapy

• ●

  Whole-course care in photodynamic therapy of colorectal cancer: A short communication(打開新的分頁／視窗)

Radiation Medicine and Protection

• ●

  Mechanisms underlying FLASH radiotherapy, a novel way to enlarge the differential responses to ionizing radiation between normal and tumor tissues(打開新的分頁／視窗)

• ●

  Prevention and treatment for radiation-induced skin injury during radiotherapy(打開新的分頁／視窗)

• ●

  HIF-1 signaling: A key orchestrator of cancer radioresistance(打開新的分頁／視窗)

Radiography

• ●

  Comparing the performance of full-field digital mammography and digital breast tomosynthesis in the post-treatment surveillance of patients with a history of breast cancer: A retrospective study(打開新的分頁／視窗)

• ●

  Breast cancer patients’ experiences on their individual care pathway: A qualitative study(打開新的分頁／視窗)

Surgical Oncology Insight

• ●

  Unsupervised clustering using multiple correspondence analysis reveals clinically-relevant demographic variables across multiple gastrointestinal cancers(打開新的分頁／視窗)

• ●

  The prognostic role of post-operative cfDNA after resection of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis(打開新的分頁／視窗)

• ●

  The effect of the pandemic on colorectal cancer in the United States: An increased disease burden(打開新的分頁／視窗)

The Breast

• ●

  Breast cancer highlights from 2023: Knowledge to guide practice and future research(打開新的分頁／視窗)

• ●

  Best of the year: Advanced breast cancer in 2023(打開新的分頁／視窗)

Translational Oncology

• ●

  Epithelial-Mesenchymal Transition in Cancer: A Historical Overview(打開新的分頁／視窗)

• ●

  3D Bioprinted cancer models: Revolutionizing personalized cancer therapy(打開新的分頁／視窗)

• ●

  MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer(打開新的分頁／視窗)

• ●

  Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection(打開新的分頁／視窗)

• ●

  m6A demethylase FTO renders radioresistance of nasopharyngeal carcinoma via promoting OTUB1-mediated anti-ferroptosis(打開新的分頁／視窗)

Elsevier’s Oncology Journal Network